Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 83

1.

Longitudinal measurement invariance of the metabolic syndrome: is the assessment of the metabolic syndrome stable over time?

Barbosa-Leiker C, Wright BR, Burns GL, Parks CD, Strand PS.

Ann Epidemiol. 2011 Feb;21(2):111-7. doi: 10.1016/j.annepidem.2010.10.001. Epub 2010 Dec 15.

PMID:
21109452
2.

Are metabolic risk factors one unified syndrome? Modeling the structure of the metabolic syndrome X.

Shen BJ, Todaro JF, Niaura R, McCaffery JM, Zhang J, Spiro A 3rd, Ward KD.

Am J Epidemiol. 2003 Apr 15;157(8):701-11.

PMID:
12697574
3.

Stability of variables associated with the metabolic syndrome from adolescence to adulthood: the Aerobics Center Longitudinal Study.

Eisenmann JC, Welk GJ, Wickel EE, Blair SN; Aerobics Center Longitudinal Study..

Am J Hum Biol. 2004 Nov-Dec;16(6):690-6.

PMID:
15495227
4.

Factor analysis of metabolic syndrome components in obese women.

Lafortuna CL, Adorni F, Agosti F, Sartorio A.

Nutr Metab Cardiovasc Dis. 2008 Mar;18(3):233-41. Epub 2007 Jun 27.

PMID:
17600693
5.
6.

Prevalence of metabolic syndrome among Filipino adults aged 20 years and over.

Tanchoco CC, Cruz AJ, Duante CA, Litonjua AD.

Asia Pac J Clin Nutr. 2003;12(3):271-6.

7.

Cholesteryl ester transfer protein in metabolic syndrome.

Sandhofer A, Kaser S, Ritsch A, Laimer M, Engl J, Paulweber B, Patsch JR, Ebenbichler CF.

Obesity (Silver Spring). 2006 May;14(5):812-8.

8.

Effects of yoga and meditation on clinical and biochemical parameters of metabolic syndrome.

Khatri D, Mathur KC, Gahlot S, Jain S, Agrawal RP.

Diabetes Res Clin Pract. 2007 Dec;78(3):e9-10. Epub 2007 Jun 26. No abstract available.

PMID:
17597249
9.

Components of the metabolic syndrome predictive of its development: a 6-year longitudinal study in Hong Kong Chinese.

Cheung BM, Wat NM, Tam S, Thomas GN, Leung GM, Cheng CH, Woo J, Janus ED, Lau CP, Lam TH, Lam KS.

Clin Endocrinol (Oxf). 2008 May;68(5):730-7. Epub 2007 Nov 2.

PMID:
17980012
10.

Consistently stable or decreased body mass index in young adulthood and longitudinal changes in metabolic syndrome components: the Coronary Artery Risk Development in Young Adults Study.

Lloyd-Jones DM, Liu K, Colangelo LA, Yan LL, Klein L, Loria CM, Lewis CE, Savage P.

Circulation. 2007 Feb 27;115(8):1004-11. Epub 2007 Feb 5.

11.

Associations between the fatty acid content of triglyceride, visceral adipose tissue accumulation, and components of the insulin resistance syndrome.

Tremblay AJ, Després JP, Piché ME, Nadeau A, Bergeron J, Alméras N, Tremblay A, Lemieux S.

Metabolism. 2004 Mar;53(3):310-7.

PMID:
15015142
12.

Elevated intraocular pressure is associated with insulin resistance and metabolic syndrome.

Oh SW, Lee S, Park C, Kim DJ.

Diabetes Metab Res Rev. 2005 Sep-Oct;21(5):434-40.

PMID:
15651065
13.

Association of low adiponectin levels with the metabolic syndrome--the Chennai Urban Rural Epidemiology Study (CURES-4).

Mohan V, Deepa R, Pradeepa R, Vimaleswaran KS, Mohan A, Velmurugan K, Radha V.

Metabolism. 2005 Apr;54(4):476-81.

PMID:
15798954
14.

Longitudinal increase in gamma-glutamyltransferase within the reference interval predicts metabolic syndrome in middle-aged Korean men.

Ryu S, Chang Y, Woo HY, Yoo SH, Choi NK, Lee WY, Kim I, Song J.

Metabolism. 2010 May;59(5):683-9. doi: 10.1016/j.metabol.2009.08.024. Epub 2009 Nov 18.

PMID:
19922966
15.

Do different dimensions of the metabolic syndrome change together over time? Evidence supporting obesity as the central feature.

Maison P, Byrne CD, Hales CN, Day NE, Wareham NJ.

Diabetes Care. 2001 Oct;24(10):1758-63.

PMID:
11574438
16.

Prevalence of metabolic syndrome in the Mediterranean region of Turkey: evaluation of hypertension, diabetes mellitus, obesity, and dyslipidemia.

Gündogan K, Bayram F, Capak M, Tanriverdi F, Karaman A, Ozturk A, Altunbas H, Gökce C, Kalkan A, Yazici C.

Metab Syndr Relat Disord. 2009 Oct;7(5):427-34. doi: 10.1089/met.2008.0068.

PMID:
19754305
17.

Increased brain fatty acid uptake in metabolic syndrome.

Karmi A, Iozzo P, Viljanen A, Hirvonen J, Fielding BA, Virtanen K, Oikonen V, Kemppainen J, Viljanen T, Guiducci L, Haaparanta-Solin M, Någren K, Solin O, Nuutila P.

Diabetes. 2010 Sep;59(9):2171-7. doi: 10.2337/db09-0138. Epub 2010 Jun 21.

19.

Physical activity and the metabolic syndrome in a tri-ethnic sample of women.

Irwin ML, Ainsworth BE, Mayer-Davis EJ, Addy CL, Pate RR, Durstine JL.

Obes Res. 2002 Oct;10(10):1030-7.

20.

Effects of 1 year of treatment with pioglitazone or rosiglitazone added to glimepiride on lipoprotein (a) and homocysteine concentrations in patients with type 2 diabetes mellitus and metabolic syndrome: a multicenter, randomized, double-blind, controlled clinical trial.

Derosa G, Cicero AF, D'Angelo A, Gaddi A, Ciccarelli L, Piccinni MN, Salvadeo SA, Pricolo F, Ferrari I, Gravina A, Ragonesi PD.

Clin Ther. 2006 May;28(5):679-88. Erratum in: Clin Ther. 2006 Sep;28(9):1483.

PMID:
16861090

Supplemental Content

Support Center